Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights

by Seini Moimoi | Mar 15, 2022 | Portfolio News

Dascena Awarded NIH Grant to Reduce Bias in Acute Coronary Syndrome Diagnosis and Treatment

by Seini Moimoi | Mar 9, 2022 | Portfolio News

Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare

by Seini Moimoi | Mar 8, 2022 | Portfolio News

Inozyme Pharma Strengthens Management Team with Two Executive Appointments

by Seini Moimoi | Mar 8, 2022 | Portfolio News

Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System

by Seini Moimoi | Mar 7, 2022 | Portfolio News

Lexeo Therapeutics Announces Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of AAA-Based Gene Therapy Candidate LX1001 in Patients with Alzheimer’s Disease

by Seini Moimoi | Mar 2, 2022 | Portfolio News

« Older Entries
Next Entries »

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2022 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer